pembrolizumab,mrna-4157
merck,moderna
['mrna-4157', 'melanoma', 'pembro']
#cedarssinaicancer at #aacr23. dr. mark faries is co-author on a study of the cancer vaccine mrna-4157 with #pembrolizumab to treat adjuvant #melanoma patients across #tumor mutational burden subgroups being presented today at 6:00am pt. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.